CDX-1401 Vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CDX-1401 Vaccine, covering 2025-03-13 to 2025-03-13. Get the full timeline:
Most recent: Clinical Trial Update: Atezolizumab, Guadecitabine, and CDX-1401 Vaccine in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 1, Phase 2]